Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment
NCT02101190
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
BIA 9-1067
Sponsor
Bial - Portela C S.A.